Pharmacological effects of carcinine on histaminergic neurons in the brain
- 1 November 2004
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 143 (5), 573-580
- https://doi.org/10.1038/sj.bjp.0705978
Abstract
1 Carcinine (beta-alanyl histamine) is an imidazole dipeptide. The present study was designed to characterize the pharmacological effects of carcinine on histaminergic activity in the brain and on certain neurobehavior. 2 Carcinine was highly selective for the histamine H3 receptor over H1 or H2 receptor (Ki (microM)=0.2939+/-0.2188 vs 3621.2+/-583.9 or 365.3+/-232.8 microM, respectively). 3 Carcinine at a dose of 20 mg kg(-1) slightly increased histidine decarboxylase (HDC) activity in the cortex (from 0.186+/-0.069 to 0.227+/-0.009 pmol mg protein(-1) min(-1)). In addition, carcinine (10, 20, and 50 mg kg(-1)) significantly decreased histamine levels in mice brain. 4 Like thioperamide, a histamine H3 receptor antagonist, carcinine (20, 50 microM) significantly increased 5-HT release from mice cortex slices, but had no apparent effect on dopamine release. 5 Carcinine (20 mg kg(-1)) significantly inhibited pentylenetetrazole-induced kindling. This inhibition was completely reversed by (R)-alpha-methylhistamine, a representative H3 receptor agonist, and alpha-fluromethylhistidine, a selective HDC inhibitor. 6 Carcinine (20 mg kg(-1)) ameliorated the learning deficit induced by scopolamine. This amelioration was reversed by (R)-alpha-methylhistamine as evaluated by the passive avoidance test in mice. 7 Like thioperamide, carcinine dose-dependently increased mice locomotor activity in the open-field test. 8 The results of this study provide first and direct evidence that carcinine, as a novel histamine H3 receptor antagonist, plays an important role in histaminergic neurons activation and might be useful in the treatment of certain diseases, such as epilepsy, and locomotor or cognitive deficit.This publication has 43 references indexed in Scilit:
- The role of histamine and the tuberomamillary nucleus in the nervous systemNature Reviews Neuroscience, 2003
- Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in miceLife Sciences, 1995
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJournal of Neural Transmission, 1993
- Histamine in brain — its role in regulation of seizure susceptibilityEpilepsy Research, 1991
- Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell-deficient W/Wv miceLife Sciences, 1991
- Existence of carcinine, a histamine-related compound, in mammalian tissuesLife Sciences, 1990
- Positive inotropic effect of carcinine in the isolated perfused guinea pig heartCritical Care Medicine, 1990
- Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decar☐ylase as a markerBrain Research, 1984
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983
- La Carcinine (β-alanyl-Histamine): Synthèse Rapide, Action Sur La Pression Sanguine Des VertébrésArchives Internationales de Physiologie et de Biochimie, 1977